Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma.
Andrew J ArmstrongAndrew B NixonAndrea CarmackQian YangTim EisenWalter M StadlerRobert J JonesJorge A GarciaUlka N VaishampayanJoel PicusRobert E HawkinsJohn D HainsworthChristian K KollmannsbergerTheodore F LoganIgor PuzanovLisa M PickeringChristopher W RyanAndrew ProtheroeDaniel J GeorgeSusan HalabiPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
In patients with metastatic NC-RCC, we identified several poor prognosis angiokines and immunomodulatory chemokines during treatment with sunitinib or everolimus, particularly OPN.